Corcept Therapeutics Long Term Deferred Assets (Quarterly) Analysis

Corcept Therapeutics, Inc. (CORT)

35.29 +0.56 (+1.61%) USD | NASDAQ | Jan 20, 16:00

34.64 -0.65 (-1.84%) After-Hours: 07:26

View Long Term Deferred Assets (Quarterly) for CORT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Axsome Therapeutics, Inc.	--
Johnson & Johnson	Upgrade
United Therapeutics Corp.	Upgrade
Ultragenyx Pharmaceutical, Inc.	--
Amicus Therapeutics, Inc.	--